Erratum: Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

J Clin Oncol. 2026 Jan 10;44(2):134. doi: 10.1200/JCO-25-02762. Epub 2025 Dec 1.
No abstract available

Publication types

  • Published Erratum